IGF2BP2 and nonpapillary renal cell carcinoma: For instance, in clear cell renal cell carcinoma (ccRCC), IGF2BP2 stabilizes salt-inducible kinase 2 (SIK2) mRNA via FTO-mediated m6A modification, enhancing autophagic flux and reducing ccRCC growth and metastasis [95].